Intuitive Surgical, Inc.

NASDAQ Global Select
Back to all articles
Bullish +65

Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

Earnings report AI-generated analysis

📈 ISRG shares gained 10.1% over the past month, significantly outperforming the S&P 500 composite which rose only 1%.

💰 The company reported quarterly revenues of $2.89 billion, surpassing analyst consensus estimates by 3.08%.

📊 Intuitive Surgical beat EPS expectations by 12.9% in the last quarter, marking a fourth consecutive quarter of earnings beats.

🔭 Analysts project current quarter EPS of $2.61, reflecting an 8.8% year-over-year increase.

🚀 Full-year consensus earnings estimates for ISRG are set at $10.74, indicating a 20.3% growth from the prior year.

💼 Revenue guidance remains strong with full-year sales estimates of $11.74 billion and next-year projections of $13.21 billion.

🏆 The stock holds a Zacks Rank #2 (Buy) based on positive trends in earnings estimate revisions.

⚠️ ISRG is graded an F on the Zacks Value Style Score, signaling it trades at a premium to its peers.

Bullish Signals
  • Shares returned +10.1% over the past month, significantly outperforming the S&P 500 composite's +1% gain.
  • The company beat consensus EPS estimates by +12.9% and revenue estimates by +3.08% in the last reported quarter.
  • Intuitive Surgical has beaten earnings estimates for four consecutive trailing quarters and topped revenue estimates three times during that period.
  • Analysts project current quarter EPS of $2.61, representing an 8.8% increase from the year-ago quarter.
  • Full-year consensus earnings estimate of $10.74 points to a +20.3% change from the prior year.
  • Revenue estimates for the current and next fiscal years are $11.74 billion and $13.21 billion, indicating +16.7% and +12.5% growth respectively.
  • The stock is assigned a Zacks Rank #2 (Buy), suggesting it may outperform the broader market in the near term.
Risk Factors
  • Intuitive Surgical is graded an F on the Zacks Value Style Score, indicating it is trading at a premium to its peers based on valuation multiples.
  • The high valuation suggests the stock price may be sensitive to any slowdown in future earnings growth or revenue expansion.
Full Analysis
Intuitive Surgical, Inc. (ISRG) has been a trending stock, outperforming the broader market with shares rising 10.1% over the past month compared to the S&P 500's 1% gain. The company recently reported quarterly revenues of $2.89 billion, beating the consensus estimate of $2.81 billion by 3.08%, while EPS of $2.8 exceeded expectations by 12.9%. This performance marks the fourth consecutive quarter where ISRG beat earnings estimates and the third time topping revenue forecasts in the trailing four quarters. Analysts maintain a strong outlook for Intuitive Surgical, with consensus earnings projections showing significant growth. For the current quarter, expected EPS is $2.61, representing an 8.8% increase year-over-year. Full-year consensus estimates stand at $10.74 (up 20.3%), while the next fiscal year projects $11.98 in earnings (an 11.6% rise). Revenue growth is also robust, with full-year and next-year sales estimates of $11.74 billion and $13.21 billion respectively, indicating sustained expansion. Despite its strong operational performance and a Zacks Rank #2 (Buy) rating suggesting near-term outperformance, Intuitive Surgical faces valuation concerns. The company is graded an F on the Zacks Value Style Score, indicating it trades at a premium relative to its peers based on traditional metrics like P/E and P/S ratios. While the high valuation suggests the market prices in significant growth potential, the stock's fair value remains tied to future earnings revisions and sustained revenue expansion.